{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:37Z","timestamp":1786982137055,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK101730"],"award-info":[{"award-number":["R01DK101730"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK102815"],"award-info":[{"award-number":["R01DK102815"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK114158"],"award-info":[{"award-number":["R01DK114158"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11914-020-00583-6","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T02:02:51Z","timestamp":1585360971000},"page":"254-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transcriptomics: a Solution for Renal Osteodystrophy?"],"prefix":"10.1007","volume":"18","author":[{"given":"Aline","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"key":"583_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","volume":"7","author":"C Dussold","year":"2019","unstructured":"\u2022\u2022 Dussold C, Gerber C, White S, Wang X, Qi L, Francis C, et al. DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone Research. 2019;7:12 This study shows that osteocyte secretion of DMP1 is reduced in the bone of mice with CKD and that DMP1 repletion reverses ROD.","journal-title":"Bone Research"},{"issue":"3","key":"583_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ki.2014.347","volume":"87","author":"RC Pereira","year":"2015","unstructured":"Pereira RC, Delany AM, Khouzam NM, Bowen RE, Freymiller EG, Salusky IB, et al. Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo. Kidney Int. 2015;87(3):593\u2013601.","journal-title":"Kidney Int"},{"issue":"5","key":"583_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.kint.2018.08.011","volume":"94","author":"RC Pereira","year":"2018","unstructured":"\u2022\u2022 Pereira RC, Salusky IB, Roschger P, Klaushofer K, Yadin O, Freymiller EG, et al. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy. Kidney Int. 2018;94(5):1002\u201312 This study shows that osteoblast and osteocyte maturation is altered in cell cultures isolated from bone biopsies of pediatric patients with ROD, suggesting that molecular changes affecting bone cells are independent of systemic perturbations.","journal-title":"Kidney Int"},{"issue":"6","key":"583_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000438461","volume":"41","author":"NX Chen","year":"2015","unstructured":"Chen NX, O'Neill KD, Allen MR, Newman CL, Moe SM. Low bone turnover in chronic kidney disease is associated with decreased VEGF-A expression and osteoblast differentiation. Am J Nephrol. 2015;41(6):464\u201373.","journal-title":"Am J Nephrol"},{"issue":"17","key":"583_CR5","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038\u201347.","journal-title":"JAMA"},{"issue":"4","key":"583_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000489897","volume":"139","author":"B Bikbov","year":"2018","unstructured":"Bikbov B, Perico N, Remuzzi G. On behalf of the GBDGDEG. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the global burden of disease 2016 study. Nephron. 2018;139(4):313\u20138.","journal-title":"Nephron"},{"issue":"6","key":"583_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","volume":"18","author":"GB Spasovski","year":"2003","unstructured":"Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant. 2003;18(6):1159\u201366.","journal-title":"Nephrol Dial Transplant"},{"issue":"6976","key":"583_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","volume":"310","author":"NA Hamdy","year":"1995","unstructured":"Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995;310(6976):358\u201363.","journal-title":"BMJ."},{"issue":"5","key":"583_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ki.1985.198","volume":"28","author":"G Coen","year":"1985","unstructured":"Coen G, Mazzaferro S, Bonucci E, Taggi F, Ballanti P, Bianchi AR, et al. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up. Kidney Int. 1985;28(5):783\u201390.","journal-title":"Kidney Int"},{"issue":"6","key":"583_CR10","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011;26(6):1368\u201376.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"583_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, et al. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;87(4):846\u201356.","journal-title":"Kidney Int"},{"issue":"8","key":"583_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","volume":"28","author":"TL Nickolas","year":"2013","unstructured":"Nickolas TL, Stein EM, Dworakowski E, Nishiyama KK, Komandah-Kosseh M, Zhang CA, et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res. 2013;28(8):1811\u201320.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"583_CR13","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006;17(11):3223\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"583_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1681\/ASN.2006050546","volume":"18","author":"LF Fried","year":"2007","unstructured":"Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007;18(1):282\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"583_CR15","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","volume":"288","author":"AM Ball","year":"2002","unstructured":"Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002;288(23):3014\u20138.","journal-title":"JAMA"},{"issue":"1","key":"583_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","volume":"51","author":"AC Dooley","year":"2008","unstructured":"Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis. 2008;51(1):38\u201344.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"583_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Leslie WD, Fraser LA, Jamal SA, Cadarette SM, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86(4):810\u20138.","journal-title":"Kidney Int"},{"key":"583_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2015.04.037","volume":"78","author":"T Isakova","year":"2015","unstructured":"Isakova T, Craven TE, Scialla JJ, Nickolas TL, Schnall A, Barzilay J, et al. Change in estimated glomerular filtration rate and fracture risk in the action to control cardiovascular risk in diabetes trial. Bone. 2015;78:23\u20137.","journal-title":"Bone"},{"issue":"2","key":"583_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007;167(2):133\u20139.","journal-title":"Arch Intern Med"},{"issue":"5","key":"583_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/ndt\/gfn678","volume":"24","author":"D Nitsch","year":"2009","unstructured":"Nitsch D, Mylne A, Roderick PJ, Smeeth L, Hubbard R, Fletcher A. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant. 2009;24(5):1539\u201344.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"583_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"AM Alem","year":"2000","unstructured":"Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58(1):396\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"583_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","volume":"25","author":"M Maravic","year":"2014","unstructured":"Maravic M, Ostertag A, Torres PU, Cohen-Solal M. Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int. 2014;25(1):159\u201365.","journal-title":"Osteoporos Int"},{"issue":"1","key":"583_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/TP.0000000000000808","volume":"100","author":"KL Naylor","year":"2016","unstructured":"Naylor KL, Jamal SA, Zou G, McArthur E, Lam NN, Leslie WD, et al. Fracture incidence in adult kidney transplant recipients. Transplantation. 2016;100(1):167\u201375.","journal-title":"Transplantation"},{"issue":"3","key":"583_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF01623276","volume":"3","author":"I Sernbo","year":"1993","unstructured":"Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int. 1993;3(3):148\u201353.","journal-title":"Osteoporos Int"},{"issue":"10","key":"583_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/jbmr.2862","volume":"31","author":"SM Kim","year":"2016","unstructured":"Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM. Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res. 2016;31(10):1803\u20139.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"583_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36(6):1115\u201321.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"583_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1681\/ASN.2012090916","volume":"24","author":"AC Beaubrun","year":"2013","unstructured":"Beaubrun AC, Kilpatrick RD, Freburger JK, Bradbury BD, Wang L, Brookhart MA. Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol. 2013;24(9):1461\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"583_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.ajkd.2017.10.007","volume":"71","author":"M Denburg","year":"2018","unstructured":"Denburg M, Nickolas TL. Declining hip fracture rates in dialysis patients: is this winning the war? Am J Kidney Dis. 2018;71(2):154\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"583_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000489671","volume":"47","author":"AK Sharma","year":"2018","unstructured":"Sharma AK, Toussaint ND, Masterson R, Holt SG, Rajapakse CS, Ebeling PR, et al. Deterioration of cortical bone microarchitecture: critical component of renal osteodystrophy evaluation. Am J Nephrol. 2018;47(6):376\u201384.","journal-title":"Am J Nephrol"},{"issue":"5","key":"583_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5414\/CN108407","volume":"82","author":"F Lima","year":"2014","unstructured":"Lima F, El-Husseini A, Monier-Faugere MC, David V, Mawad H, Quarles D, et al. FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis. Clin Nephrol. 2014;82(5):287\u201395.","journal-title":"Clin Nephrol"},{"issue":"6","key":"583_CR31","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","volume":"91","author":"FG Graciolli","year":"2017","unstructured":"\u2022\u2022 Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, et al. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney Int. 2017;91(6):1436\u201346 This study analyzed bone expression of several bone proteins, including FGF23 and sclerostin, in biopsies from healthy patients and patients with CKD 2\u20135 as well as bone remodeling markers. The main findings were that distinct osteocyte populations produce FGF23 and Sclerostin in ROD.","journal-title":"Kidney Int"},{"issue":"6","key":"583_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2215\/CJN.09950818","volume":"14","author":"S Keronen","year":"2019","unstructured":"\u2022 Keronen S, Martola L, Finne P, Burton IS, Kroger H, Honkanen E. Changes in bone Histomorphometry after kidney transplantation. Clin J Am Soc Nephrol. 2019;14(6):894\u2013903 This article shows the lack of relationship between bone mineral density and bone biomarkers and bone metabolism changes.","journal-title":"Clin J Am Soc Nephrol"},{"key":"583_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2015.04.021","volume":"77","author":"CL Newman","year":"2015","unstructured":"Newman CL, Chen NX, Smith E, Smith M, Brown D, Moe SM, et al. Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions. Bone. 2015;77:50\u20136.","journal-title":"Bone."},{"key":"583_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bone.2019.05.002","volume":"125","author":"EMB McNerny","year":"2019","unstructured":"McNerny EMB, Buening DT, Aref MW, Chen NX, Moe SM, Allen MR. Time course of rapid bone loss and cortical porosity formation observed by longitudinal muCT in a rat model of CKD. Bone. 2019;125:16\u201324.","journal-title":"Bone."},{"key":"583_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bone.2015.07.015","volume":"81","author":"Y Iwasaki","year":"2015","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Matsugaki A, Nakano T, Fukagawa M. Altered material properties are responsible for bone fragility in rats with chronic kidney injury. Bone. 2015;81:247\u201354.","journal-title":"Bone."},{"issue":"1","key":"583_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"\u2022 Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline update: what\u2019s changed and why it matters. Kidney Int. 2017;92(1):26\u201336 This summarizes updates in KDIGO guidelines from the initial 2009 guidelines.","journal-title":"Kidney Int"},{"issue":"9","key":"583_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/M16-2752","volume":"166","author":"LM Wilson","year":"2017","unstructured":"Wilson LM, Rebholz CM, Jirru E, Liu MC, Zhang A, Gayleard J, et al. Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2017;166(9):649\u201358.","journal-title":"Ann Intern Med"},{"issue":"1","key":"583_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12882-017-0692-5","volume":"18","author":"HS Jorgensen","year":"2017","unstructured":"Jorgensen HS, Winther S, Bottcher M, Hauge EM, Rejnmark L, Svensson M, et al. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol. 2017;18(1):284.","journal-title":"BMC Nephrol"},{"issue":"1","key":"583_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00774-018-0902-7","volume":"37","author":"MFP Santos","year":"2019","unstructured":"\u2022\u2022 Santos MFP, Hernandez MJ, de Oliveira IB, Siqueira FR, Dominguez WV, Dos Reis LM, et al. Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures. J Bone Miner Metab. 2019;37(1):125\u201333 This study shows increased fracture prevalence in patients with ROD and reduced cortical bone DMP1 expression, suggesting that production and secretion of this protein in ROD is of utmost significance.","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"583_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, et al. Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis. 2016;67(4):559\u201366.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"583_CR41","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00198-017-3956-9","volume":"28","author":"ID Marques","year":"2017","unstructured":"Marques ID, Araujo MJ, Graciolli FG, Reis LM, Pereira RM, Custodio MR, et al. Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int. 2017;28(5):1675\u201383.","journal-title":"Osteoporos Int"},{"issue":"5","key":"583_CR42","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","volume":"29","author":"S Salam","year":"2018","unstructured":"Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R. Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol. 2018;29(5):1557\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"583_CR43","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1681\/ASN.2018030289","volume":"29","author":"TL Nickolas","year":"2018","unstructured":"\u2022\u2022 Nickolas TL. The quest for better biomarkers of bone turnover in CKD. J Am Soc Nephrol. 2018;29(5):1353\u20135 This review emphasizes the lack of definition of bone status and turnover by the existing serum biomarkers.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"583_CR44","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1681\/ASN.2018050561","volume":"29","author":"EO Gosmanova","year":"2018","unstructured":"Gosmanova EO, Gosmanov AR. Novel approaches for assessment of bone turnover in CKD: is new always better? J Am Soc Nephrol. 2018;29(9):2443.","journal-title":"J Am Soc Nephrol"},{"key":"583_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2369-15-69","volume":"15","author":"GO Ferrari","year":"2014","unstructured":"Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models. BMC Nephrol. 2014;15:69.","journal-title":"BMC Nephrol"},{"key":"583_CR46","doi-asserted-by":"crossref","unstructured":"Christov M, Clark AR, Corbin B, Hakroush S, Rhee EP, Saito H, et al. Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI insight. 2018;3(4).","DOI":"10.1172\/jci.insight.95091"},{"issue":"1","key":"583_CR47","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/s41598-017-02351-6","volume":"7","author":"T Tani","year":"2017","unstructured":"Tani T, Orimo H, Shimizu A, Tsuruoka S. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease. Sci Rep. 2017;7(1):2233.","journal-title":"Sci Rep"},{"key":"583_CR48","doi-asserted-by":"publisher","first-page":"1659071","DOI":"10.1155\/2017\/1659071","volume":"2017","author":"B Frauscher","year":"2017","unstructured":"Frauscher B, Artinger K, Kirsch AH, Aringer I, Moschovaki-Filippidou F, Ketszeri M, et al. A new murine model of chronic kidney disease-mineral and bone disorder. Int J Endocrinol. 2017;2017:1659071.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"583_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ki.2008.456","volume":"75","author":"Sharon M. Moe","year":"2009","unstructured":"Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, et al. A rat model of chronic kidney disease-mineral bone disorder. Kidney Int. 2009;75(2):176\u201384.","journal-title":"Kidney International"},{"issue":"6","key":"583_CR50","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/ndt\/gfy287","volume":"34","author":"N Carrillo-Lopez","year":"2019","unstructured":"Carrillo-Lopez N, Panizo S, Alonso-Montes C, Martinez-Arias L, Avello N, Sosa P, et al. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Nephrol Dial Transplant. 2019;34(6):934\u201341.","journal-title":"Nephrol Dial Transplant"},{"key":"583_CR51","doi-asserted-by":"publisher","first-page":"8304","DOI":"10.1038\/srep08304","volume":"5","author":"N Sun","year":"2015","unstructured":"Sun N, Guo Y, Liu W, Densmore M, Shalhoub V, Erben RG, et al. FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice. Sci Rep. 2015;5:8304.","journal-title":"Sci Rep"},{"key":"583_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fendo.2018.00311","volume":"9","author":"O Andrukhova","year":"2018","unstructured":"Andrukhova O, Schuler C, Bergow C, Petric A, Erben RG. Augmented fibroblast growth factor-23 secretion in bone locally contributes to impaired bone mineralization in chronic kidney disease in mice. Front Endocrinol. 2018;9:311.","journal-title":"Front Endocrinol"},{"issue":"10","key":"583_CR53","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/ndt\/gft234","volume":"28","author":"RB de Oliveira","year":"2013","unstructured":"de Oliveira RB, Graciolli FG, dos Reis LM, Cancela AL, Cuppari L, Canziani ME, et al. Disturbances of Wnt\/beta-catenin pathway and energy metabolism in early CKD: effect of phosphate binders. Nephrol Dial Transplant. 2013;28(10):2510\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"583_CR54","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CN109650","volume":"91","author":"F Lima","year":"2019","unstructured":"Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers. Clin Nephrol. 2019;91(4):222\u201330.","journal-title":"Clin Nephrol"},{"issue":"11","key":"583_CR55","doi-asserted-by":"publisher","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","volume":"8","author":"Juliana C. Ferreira","year":"2013","unstructured":"Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y, Jorgetti V, Schiavi S, Moys\u00e9s RM Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin? PLoS One 2013;8(11):e79721.","journal-title":"PLoS ONE"},{"issue":"3","key":"583_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.2372","volume":"30","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, et al. Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res. 2015;30(3):499\u2013509.","journal-title":"J Bone Miner Res"},{"key":"583_CR57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2017.11.015","volume":"107","author":"N Kaesler","year":"2018","unstructured":"Kaesler N, Verhulst A, De Mare A, Deck A, Behets GJ, Hyusein A, et al. Sclerostin deficiency modifies the development of CKD-MBD in mice. Bone. 2018;107:115\u201323.","journal-title":"Bone"},{"issue":"1","key":"583_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","volume":"93","author":"MJ Williams","year":"2018","unstructured":"Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, et al. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int. 2018;93(1):147\u201358.","journal-title":"Kidney Int"},{"issue":"1","key":"583_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","volume":"91","author":"T Sugatani","year":"2017","unstructured":"Sugatani T, Agapova OA, Fang Y, Berman AG, Wallace JM, Malluche HH, et al. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. Kidney Int. 2017;91(1):86\u201395.","journal-title":"Kidney Int"},{"issue":"4","key":"583_CR60","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.kint.2016.06.019","volume":"90","author":"D Cejka","year":"2016","unstructured":"Cejka D, Parada-Rodriguez D, Pichler S, Marculescu R, Kramer I, Kneissel M, et al. Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease. Kidney Int. 2016;90(4):828\u201334.","journal-title":"Kidney Int"},{"issue":"8","key":"583_CR61","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, et al. CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol. 2014;25(8):1760\u201373.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"583_CR62","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/jcp.25732","volume":"232","author":"E Della Bella","year":"2017","unstructured":"Della Bella E, Pagani S, Giavaresi G, Capelli I, Comai G, Donadei C, et al. Uremic serum impairs osteogenic differentiation of human bone marrow mesenchymal stromal cells. J Cell Physiol. 2017;232(8):2201\u20139.","journal-title":"J Cell Physiol"},{"issue":"1","key":"583_CR63","doi-asserted-by":"publisher","first-page":"15385","DOI":"10.1038\/s41598-018-33979-7","volume":"8","author":"MA Aleksinskaya","year":"2018","unstructured":"\u2022\u2022 Aleksinskaya MA, Monge M, Siebelt M, Slot EM, Koekkoek KM, de Bruin RG, et al. Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche. Sci Rep. 2018;8(1):15385 This study shows profound changes in hematopoietic stem cell (HSC) niche in CKD and suggests that permanent changes in HSC might explain the loss of homeostatic potential in CKD.","journal-title":"Sci Rep"},{"issue":"8","key":"583_CR64","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1096\/fj.10-177816","volume":"25","author":"A Martin","year":"2011","unstructured":"Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 2011;25(8):2551\u201362.","journal-title":"FASEB J"},{"issue":"9","key":"583_CR65","doi-asserted-by":"publisher","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","volume":"7","author":"B Dai","year":"2012","unstructured":"Dai B, David V, Martin A, Huang J, Li H, Jiao Y, et al. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One. 2012;7(9):e44161.","journal-title":"PLoS One"},{"issue":"11","key":"583_CR66","doi-asserted-by":"publisher","first-page":"e0142924","DOI":"10.1371\/journal.pone.0142924","volume":"10","author":"AA Portale","year":"2015","unstructured":"Portale AA, Zhang MY, David V, Martin A, Jiao Y, Gu W, et al. Characterization of FGF23-dependent Egr-1 cistrome in the mouse renal proximal tubule. PLoS One. 2015;10(11):e0142924.","journal-title":"PLoS One"},{"key":"583_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2018.04.006","volume":"113","author":"LA Khayal","year":"2018","unstructured":"\u2022 Khayal LA, Grunhagen J, Provaznik I, Mundlos S, Kornak U, Robinson PN, et al. Transcriptional profiling of murine osteoblast differentiation based on RNA-seq expression analyses. Bone. 2018;113:29\u201340 This study analyzed the transcriptomic profile of differentiated murine primary calvaria osteoblasts and defined the key genetic regulatory mechanisms of osteoblast differentiation.","journal-title":"Bone"},{"issue":"1","key":"583_CR68","doi-asserted-by":"publisher","first-page":"e0204197","DOI":"10.1371\/journal.pone.0204197","volume":"14","author":"LM Luttrell","year":"2019","unstructured":"\u2022 Luttrell LM, Dar MS, Gesty-Palmer D, El-Shewy HM, Robinson KM, Haycraft CJ, et al. Transcriptomic characterization of signaling pathways associated with osteoblastic differentiation of MC-3T3E1 cells. PLoS One. 2019;14(1):e0204197 This article identified the signaling pathways involved in the differentiation of the murine osteoblastic cell line MC3T3-E1, based on the temporal sequence of changes in gene expression profiles.","journal-title":"PLoS One"},{"issue":"3","key":"583_CR69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/jre.12309","volume":"51","author":"BG Matthews","year":"2016","unstructured":"Matthews BG, Roguljic H, Franceschetti T, Roeder E, Matic I, Vidovic I, et al. Gene-expression analysis of cementoblasts and osteoblasts. J Periodontal Res. 2016;51(3):304\u201312.","journal-title":"J Periodontal Res"},{"issue":"1","key":"583_CR70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli S, Faridani OR, Bjorklund AK, Winberg G, Sagasser S, Sandberg R. Full-length RNA-seq from single cells using smart-seq2. Nat Protoc. 2014;9(1):171\u201381.","journal-title":"Nat Protoc"},{"issue":"7725","key":"583_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-018-0554-8","volume":"562","author":"S Debnath","year":"2018","unstructured":"\u2022\u2022 Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature. 2018;562(7725):133\u20139 This study identified several subsets of periosteal stem cells, and defined one specific cell population involved in intramembranous bone formation.","journal-title":"Nature"},{"key":"583_CR72","unstructured":"\u2022 Liu S, Stroncek DF, Zhao Y, Chen V, Shi R, Chen J, et al. Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture. Journal of translational medicine. 2019;17(1):23 This study of single cell RNA sequencing analyses of early passage bone marrow stromal cells, highlights cell heterogeneity and identified a subpopulation of cells expressing high levels of fibroblast growth factor receptor 2."},{"issue":"2","key":"583_CR73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.celrep.2019.06.031","volume":"28","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Krishnan I, Tenen DE, Matkins V, Camacho V, Patel S, et al. Mapping distinct bone marrow niche populations and their differentiation paths. Cell Rep. 2019;28(2):302\u201311 e5.","journal-title":"Cell Rep"},{"issue":"6293","key":"583_CR74","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.aaf1204","volume":"352","author":"BB Lake","year":"2016","unstructured":"Lake BB, Ai R, Kaeser GE, Salathia NS, Yung YC, Liu R, et al. Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science (New York, NY). 2016;352(6293):1586\u201390.","journal-title":"Science (New York, NY)"},{"issue":"6302","key":"583_CR75","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1126\/science.aad7038","volume":"353","author":"N Habib","year":"2016","unstructured":"Habib N, Li Y, Heidenreich M, Swiech L, Avraham-Davidi I, Trombetta JJ, et al. Div-Seq: single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons. Science (New York, NY). 2016;353(6302):925\u20138.","journal-title":"Science (New York, NY)"},{"key":"583_CR76","doi-asserted-by":"publisher","first-page":"12139","DOI":"10.1038\/ncomms12139","volume":"7","author":"S Nichterwitz","year":"2016","unstructured":"Nichterwitz S, Chen G, Aguila Benitez J, Yilmaz M, Storvall H, Cao M, et al. Laser capture microscopy coupled with smart-seq2 for precise spatial transcriptomic profiling. Nat Commun. 2016;7:12139.","journal-title":"Nat Commun"},{"issue":"10","key":"583_CR77","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/jbmr.1946","volume":"28","author":"UM Ayturk","year":"2013","unstructured":"Ayturk UM, Jacobsen CM, Christodoulou DC, Gorham J, Seidman JG, Seidman CE, et al. An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutations. J Bone Miner Res. 2013;28(10):2081\u201393.","journal-title":"J Bone Miner Res"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00583-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-020-00583-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-020-00583-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T20:36:50Z","timestamp":1616877410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-020-00583-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s11914-020-00583-6","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]},"assertion":[{"value":"28 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This article does not contain any studies with human or animals subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}